Literature DB >> 9886460

GTP cyclohydrolase deficiency; intrafamilial variation in clinical phenotype, including levodopa responsiveness.

R Robinson1, G T McCarthy, O Bandmann, M Dobbie, R Surtees, N W Wood.   

Abstract

A family with a dominant form of partial GTP cyclohydrolase deficiency is described. Clinical severity varied from mild involvement with complete responsiveness to levodopa to severe dystonia precluding any voluntary activity including talking, progressive contractures, and only partial responsiveness to levodopa. Although there are several possible reasons for intrafamilial variability, any patient with dystonia, the cause of which is not clearly identified, should receive a trial of levodopa.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9886460      PMCID: PMC1736164          DOI: 10.1136/jnnp.66.1.86

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  8 in total

1.  Expanded motor and psychiatric phenotype in autosomal dominant Segawa syndrome due to GTP cyclohydrolase deficiency.

Authors:  J L K Van Hove; J Steyaert; G Matthijs; E Legius; P Theys; R Wevers; A Romstad; L B Møller; K Hedrich; D Goriounov; N Blau; C Klein; P Casaer
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-01       Impact factor: 10.154

2.  Segawa syndrome due to mutation Q89X in the GCH1 gene: a possible founder effect in Córdoba (southern Spain).

Authors:  Eduardo López-Laso; Juan José Ochoa-Sepúlveda; Juan José Ochoa-Amor; Enrique Bescansa-Heredero; Rafael Camino-León; Francisco Javier Gascón-Jiménez; Maria Elena Mateos-González; Juan Luis Pérez-Navero; José Ignacio Lao-Villadóniga; Aida Ormazabal; Rafael Artuch; Katrin Beyer
Journal:  J Neurol       Date:  2009-06-16       Impact factor: 4.849

3.  Urinary neopterin and phenylalanine loading test as tools for the biochemical diagnosis of segawa disease.

Authors:  Vincenzo Leuzzi; Claudia Carducci; Flavia Chiarotti; Daniela D'Agnano; Maria Teresa Giannini; Italo Antonozzi; Carla Carducci
Journal:  JIMD Rep       Date:  2012-04-18

4.  Severe pyridine nucleotide depletion in fibroblasts from Lesch-Nyhan patients.

Authors:  Lynette D Fairbanks; Gabriella Jacomelli; Vanna Micheli; Tina Slade; H Anne Simmonds
Journal:  Biochem J       Date:  2002-08-15       Impact factor: 3.857

5.  Dyskinesias as a limiting factor in the treatment of Segawa disease.

Authors:  Eduardo López-Laso; Katrin Beyer; Thomas Opladen; Rafael Artuch; Rachel Saunders-Pullman
Journal:  Pediatr Neurol       Date:  2012-06       Impact factor: 3.372

6.  Neuropsychiatric and sleep study in autosomal dominant dopa-responsive dystonia.

Authors:  Ailton C Alves Júnior; Maurício V Daker; Alexei M C Machado; Alan S Luna; Dirceu C Valladares Neto; Eugenia R Valadares
Journal:  Mol Genet Metab Rep       Date:  2022-04-18

Review 7.  Consensus guideline for the diagnosis and treatment of tetrahydrobiopterin (BH4) deficiencies.

Authors:  Thomas Opladen; Eduardo López-Laso; Elisenda Cortès-Saladelafont; Toni S Pearson; H Serap Sivri; Yilmaz Yildiz; Birgit Assmann; Manju A Kurian; Vincenzo Leuzzi; Simon Heales; Simon Pope; Francesco Porta; Angeles García-Cazorla; Tomáš Honzík; Roser Pons; Luc Regal; Helly Goez; Rafael Artuch; Georg F Hoffmann; Gabriella Horvath; Beat Thöny; Sabine Scholl-Bürgi; Alberto Burlina; Marcel M Verbeek; Mario Mastrangelo; Jennifer Friedman; Tessa Wassenberg; Kathrin Jeltsch; Jan Kulhánek; Oya Kuseyri Hübschmann
Journal:  Orphanet J Rare Dis       Date:  2020-05-26       Impact factor: 4.123

Review 8.  Dystonia Diagnosis: Clinical Neurophysiology and Genetics.

Authors:  Lazzaro di Biase; Alessandro Di Santo; Maria Letizia Caminiti; Pasquale Maria Pecoraro; Simona Paola Carbone; Vincenzo Di Lazzaro
Journal:  J Clin Med       Date:  2022-07-19       Impact factor: 4.964

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.